Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04715386 · ClinicalTrials.gov registry record
Feasibility in the Prophylaxis of Radiation Dermatitis Severity
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 14
- Enrollment target
NCT04715386: Clinical Trial study, sponsored by Mayo Clinic.
NCT04715386 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04715386 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
To compare radiation dermatitis severity in irradiated skin protected by an agent verses uncovered skin based on photographs and track patient reported outcomes with use of the agent.
Interventions
- DRUG StrataXRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2024-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04715386
The ClinicalTrials.gov registry entry for NCT04715386 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StrataXRT is the first listed.
NCT04715386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04715386 about?
NCT04715386 is a clinical study titled "Feasibility in the Prophylaxis of Radiation Dermatitis Severity". To compare radiation dermatitis severity in irradiated skin protected by an agent verses uncovered skin based on photographs and track patient reported outcomes with use of the agent.
What is the current status of trial NCT04715386?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2020-06-22. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT04715386?
The interventions under investigation include: StrataXRT (DRUG).
Who is sponsoring clinical trial NCT04715386?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.